SLONIN JONATHAN
Reporting owner on Forms 3, 4 and 5, CIK 1875723.
SLONIN JONATHAN reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PCRX · Pacira BioSciences, Inc.CIK 1396814 | officer (Chief Medical Officer) | 1 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PCRX · Pacira BioSciences, Inc.Common Stock | 2026-11-17 | D returned to the issuer | -216,729.67 | $36.5 | 0 | Form 4 |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -35,500 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -14,137 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -10,000 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -24,800 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -27,500 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -10,000 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-074524 | Pacira BioSciences, Inc. | 2026-11-17 |